| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
Kidney (Chronic renal failure)CreatinineAldosteroneAnemia (Renal)RAAS (Renin angiotensin system)ProteomicsSarcopeniaObesityUric acid (Hyperuricemia)Vitamin DStatinDiuretic agents (BASKET)Kidney (Glomerulus)ZONABHomocysteineFibrosisReceptor (PPAR)Acidosis (metabolic)Cardiorenal syndromeRAAS (AngiotensinII)Kidney (Pressure natriuresis)Kidney (Fibrosis)Kidney (Microcirculation)Kidney (Medulla)Redox (BASKET)Nitric oxide NONADPH oxidaseKidney (Mesangial cell)Receptor (Mineralcorticoid)EndothelinEndothelial dysfunctionNifedipineNitrosonifedipineReceptor (Pro Renin)HIF1alpha und HIF1 (BASKET)Prolyl hydroxylasesImplanted cardioverter defibrillatorCardiovascular riskArterial hypertension (BASKET)HepcidinCinacalcetPTH (Hyperparathyreoidism secondary)| 1 | 2002 | Chronic renal disease. | 
| + | - | nl | BMJ 325(7355):85-90 (2002) |
| 2 | 2010 | Chronic kidney disease: whom to screen and how to treat, part 1: definition, epidemiology, and laboratory testing. | 
| + | - | nl | South Med J 103(2):140-6 (2010) |
| 3 | 2008 | The ABCDEs of CKD: a simple approach to early detection and management. | 
| + | - | nl | South Med J 101(10):1001-6 (2008) |
| 4 | 2004 | Proteinuria and microalbuminuria in adults: significance, evaluation, and treatment. | 
| + | - | nl | South Med J 97(10):969-79 (2004) |
| 5 | 1994 | Pathophysiology of progressive renal failure. | 
| + | - | nl | South Med J 87(10):1028-33 (1994) |
| 6 | 2009 | Discharging patients from the nephrology clinic to primary care--will they get appropriate monitoring of renal function? | 
| + | - | nl | QJM 102(6):425-8 (2009) |
| 7 | 2008 | Role of chronic hypoxia and hypoxia inducible factor in kidney disease. | 
| + | - | nl | Chin Med J (Engl) 121(3):257-64 (2008) |
| 8 | 2003 | Progression of chronic renal failure. | 
| + | - | nl | Arch Intern Med 163(12):1417-29 (2003) |
| 9 | 1998 | Chronic renal insufficiency: a diagnostic and therapeutic approach. | 
| + | - | nl | Arch Intern Med 158(16):1743-52 (1998) |
| 10 | 2006 | Natural history of elevated creatinine levels. | 
| + | - | nl | Can Fam Physician 52(10):1264-5 (2006) |
| 11 | 2001 | Identifying and slowing progressive chronic renal failure. | 
| + | - | nl | Can Fam Physician 47(-):2512-8 (2001) |
| 12 | 2000 | End-stage renal disease. Timely, appropriate treatment is crucial. | 
| + | - | nl | Can Fam Physician 46(-):511-2, 522-4 (2000) |
| 13 | 2008 | Chronic kidney disease and its complications. | 
| + | - | nl | Prim Care 35(2):329-44, vii (2008) |
| 14 | 2001 | Cardiovascular complications of renal disease. | 
| + | - | nl | Heart 86(4):459-66 (2001) |
| 15 | 2007 | Causes and consequences of chronic kidney disease: implications for managed health care. | 
| + | - | nl | J Manag Care Pharm 13(3 Suppl):S1-9 (2007) |
| 16 | 1980 | Nutritional assessment and treatment of chronic renal failure. | 
| + | - | nl | Am J Clin Nutr 33(7):1586-97 (1980) |
| 17 | 1980 | Symposium on nutrition in renal disease. Proceedings of the Second International Congress on Nutrition in Renal Disease; June 13--15, 1979, Bologna, Italy. | 
| + | - | nl | Am J Clin Nutr 33(7):1342-702 (1980) |
| 18 | 1997 | Abnormal lipid metabolism and renal disorders. | 
| + | - | nl | Tohoku J Exp Med 181(3):321-37 (1997) |
| 19 | 1992 | Preservation of renal function in chronic renal failure. | 
| + | - | nl | Tohoku J Exp Med 166(1):165-83 (1992) |
| 20 | 2009 | Early angiography in patients with chronic kidney disease: a collaborative systematic review. | 
| + | - | nl | Clin J Am Soc Nephrol 4(6):1032-43 (2009) |
| 21 | 2009 | Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis. | 
| + | - | nl | Clin J Am Soc Nephrol 4(3):542-51 (2009) Navaneethan SD |
| 22 | 2006 | Do we know the correct hemoglobin target for anemic patients with chronic kidney disease? | 
| + | - | nl | Clin J Am Soc Nephrol 1(4):678-84 (2006) |
| 23 | 2006 | Aldosterone antagonism in chronic kidney disease. | 
| + | - | nl | Clin J Am Soc Nephrol 1(4):668-77 (2006) Ponda MP |
| 24 | 2009 | Optimal preparation for ESRD. | 
| + | - | nl | Clin J Am Soc Nephrol 4 Suppl 1(-):S110-3 (2009) |
| 25 | 2008 | Nitric oxide deficiency in chronic kidney disease. | 
| + | - | nl | Am J Physiol Renal Physiol 294(1):F1-9 (2008) |
| 26 | 1971 | Function of the chronically diseased kidney. The adaptive nephron. | 
| + | - | nl | Circ Res 28(5):Suppl 2:1-13 (1971) |
| 27 | 2008 | Treating elderly people with diabetes and stages 3 and 4 chronic kidney disease. | 
| + | - | nl | Clin J Am Soc Nephrol 3(4):1185-94 (2008) |
| 28 | 2007 | The unique character of cardiovascular disease in chronic kidney disease and its implications for treatment with lipid-lowering drugs. | 
| + | - | nl | Clin J Am Soc Nephrol 2(4):766-85 (2007) |
| 29 | 2004 | Causes and consequences of increased sympathetic activity in renal disease. | 
| + | - | nl | Hypertension 43(4):699-706 (2004) |
| 30 | 2003 | Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. | 
| + | - | nl | Hypertension 42(5):1050-65 (2003) |
| 31 | 1993 | Essential hypertension: a renal disease? A review and update of the evidence. | 
| + | - | nl | Hypertension 21(3):380-90 (1993) |
| 32 | 1980 | Antihypertensive functions of the kidney: Arthur C. Corcoran memorial lecture. | 
| + | - | nl | Hypertension 2(4):444-64 (1980) |
| 33 | 2009 | Timing of onset of CKD-related metabolic complications. | 
| + | - | nl | J Am Soc Nephrol 20(1):164-71 (2009) |
| 34 | 2008 | Staging of chronic kidney disease: time for a course correction. | 
| + | - | nl | J Am Soc Nephrol 19(5):844-6 (2008) |
| 35 | 2007 | Frontiers in nephrology: early atherosclerosis--a view beyond the lumen. | 
| + | - | nl | J Am Soc Nephrol 18(11):2836-42 (2007) |
| 36 | 2007 | Frontiers in nephrology: viewing the kidney through the heart--endothelial dysfunction in chronic kidney disease. | 
| + | - | nl | J Am Soc Nephrol 18(11):2833-5 (2007) |
| 37 | 2006 | Chronic kidney disease and mortality risk: a systematic review. | 
| + | - | nl | J Am Soc Nephrol 17(7):2034-47 (2006) |
| 38 | 2004 | Sympathetic hyperactivity in chronic renal failure: a wake-up call. | 
| + | - | nl | J Am Soc Nephrol 15(3):524-37 (2004) |
| 39 | 1991 | Cardiovascular complications in renal failure. | 
| + | - | nl | J Am Soc Nephrol 2(6):1053-62 (1991) |
| 40 | 1991 | The natural history of myocardial disease in dialysis patients. | 
| + | - | nl | J Am Soc Nephrol 2(1):2-12 (1991) |
| 41 | 2001 | Coronary artery disease in uremia: Etiology, diagnosis, and therapy. | 
| + | - | nl | Kidney Int 60(6):2059-78 (2001) |
| 42 | 1995 | Treatment of children with chronic renal failure. | 
| + | - | nl | Kidney Int 47(3):951-61 (1995) |
| 43 | 2007 | Chronic kidney disease: effects on the cardiovascular system. | 
| + | - | nl | Circulation 116(1):85-97 (2007) |
| 44 | 2008 | Diagnosis and management of chronic kidney disease. | 
| + | - | nl | Mayo Clin Proc 83(9):1064-9 (2008) |
| 45 | 2006 | Late referral of patients with chronic kidney disease: no time to waste. | 
| + | - | nl | Mayo Clin Proc 81(11):1487-94 (2006) Sprangers B |
| 46 | 2006 | Early referral for chronic kidney disease: good for those who need it, but who are they? | 
| + | - | nl | Mayo Clin Proc 81(11):1420-2 (2006) |
| 47 | 1998 | Uraemic cardiomyopathy. | 
| + | - | nl | Nephrol Dial Transplant 13 Suppl 4(-):39-43 (1998) |
| 48 | 2003 | National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. | 
| + | - | nl | Pediatrics 111(6 Pt 1):1416-21 (2003) |
| 49 | 2008 | Guidelines for the management of chronic kidney disease. | 
| + | - | nl | CMAJ 179(11):1154-62 (2008) Levin A |
| 50 | 2008 | Progress and promise in the management of chronic kidney disease. | 
| + | - | nl | CMAJ 179(11):1107-8 (2008) |
| 51 | 2002 | Nephrology: 3. Safe drug prescribing for patients with renal insufficiency. | 
| + | - | nl | CMAJ 166(4):473-7 (2002) |
| 52 | 1993 | Musculoskeletal manifestations of chronic renal insufficiency. | 
| + | - | nl | Radiographics 13(2):357-79 (1993) |
| 53 | 2011 | The role of statins in chronic kidney disease. | 
| + | - | nl | Am J Nephrol 34(3):195-202 (2011) |
| 54 | 2010 | Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease. | 
| + | - | nl | Am J Nephrol 31(6):541-50 (2010) |
| 55 | 2010 | The use of targeted biomarkers for chronic kidney disease. | 
| + | - | nl | Adv Chronic Kidney Dis 17(6):469-79 (2010) |
| 56 | 2010 | Mass spectrometry in chronic kidney disease research. | 
| + | - | nl | Adv Chronic Kidney Dis 17(6):455-68 (2010) |
| 57 | 2008 | Progression from acute kidney injury to chronic kidney disease: a pediatric perspective. | 
| + | - | nl | Adv Chronic Kidney Dis 15(3):278-83 (2008) |
| 58 | 2010 | Review of muscle wasting associated with chronic kidney disease. | 
| + | - | nl | Am J Clin Nutr 91(4):1128S-1132S (2010) |
| 59 | 2005 | Survival advantages of obesity in dialysis patients. | 
| + | - | nl | Am J Clin Nutr 81(3):543-54 (2005) |
| 60 | 2008 | The role of hyperuricemia and gout in kidney and cardiovascular disease. | 
| + | - | nl | Cleve Clin J Med 75 Suppl 5(-):S13-6 (2008) |
| 61 | 2009 | Vitamin D deficiency in children with chronic kidney disease: uncovering an epidemic. | 
| + | - | nl | Pediatrics 123(3):791-6 (2009) |
| 62 | 2007 | Effects of statins on renal function. | 
| + | - | nl | Mayo Clin Proc 82(11):1381-90 (2007) |
| 63 | 2002 | New insights into diuretic use in patients with chronic renal disease. | 
| + | - | nl | J Am Soc Nephrol 13(3):798-805 (2002) |
| 64 | 2002 | Role of the microvascular endothelium in progressive renal disease. | 
| + | - | nl | J Am Soc Nephrol 13(3):806-16 (2002) |
| 65 | 2003 | Prevention of the development and progression of renal disease. | 
| + | - | nl | J Am Soc Nephrol 14(7 Suppl 2):S144-7 (2003) |
| 66 | 2009 | The case for using albuminuria in staging chronic kidney disease. | 
| + | - | nl | J Am Soc Nephrol 20(3):465-8 (2009) |
| 67 | 2007 | Lipoprotein metabolism and lipid management in chronic kidney disease. | 
| + | - | nl | J Am Soc Nephrol 18(4):1246-61 (2007) |
| 68 | 2007 | More on renal disease progression: is interstitial inflammation truly protective? | 
| + | - | nl | J Am Soc Nephrol 18(6):1630-2 (2007) Perico N |
| 69 | 2009 | Sympathetic activation in chronic renal failure. | 
| + | - | nl | J Am Soc Nephrol 20(5):933-9 (2009) |
| 70 | 2009 | Metabolic acidosis and progression of chronic kidney disease. | 
| + | - | nl | J Am Soc Nephrol 20(9):1869-70 (2009) Frassetto LA |
| 71 | 2006 | Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering? | 
| + | - | nl | Nephrol Dial Transplant 21(5):1161-6 (2006) |
| 72 | 2006 | Are peroxisome proliferator-activated receptors new therapeutic targets in diabetic and non-diabetic nephropathies? | 
| + | - | nl | Nephrol Dial Transplant 21(10):2696-702 (2006) |
| 73 | 2006 | Hearing in renal failure. | 
| + | - | nl | Nephrol Dial Transplant 21(11):3023-30 (2006) |
| 74 | 2004 | Sympathetic hyperactivity in chronic kidney disease. | 
| + | - | nl | Nephrol Dial Transplant 19(6):1354-7 (2004) |
| 75 | 2009 | Progress with the European Society for Paediatric Nephrology (ESPN)/ERA-EDTA Registry for children with established renal failure (ERF). | 
| + | - | nl | Nephrol Dial Transplant 24(9):2615-7 (2009) |
| 76 | 2011 | Consequences and therapy of the metabolic acidosis of chronic kidney disease. | 
| + | - | nl | Pediatr Nephrol 26(1):19-28 (2011) |
| 77 | 2011 | Heat shock proteins in chronic kidney disease. | 
| + | - | nl | Pediatr Nephrol 26(7):1031-7 (2011) |
| 78 | 2008 | Therapeutic strategies to slow chronic kidney disease progression. | 
| + | - | nl | Pediatr Nephrol 23(5):705-16 (2008) |
| 79 | 2008 | Hypertension in children with chronic kidney disease: pathophysiology and management. | 
| + | - | nl | Pediatr Nephrol 23(3):363-71 (2008) |
| 80 | 2009 | End-stage renal disease: in vivo diffusion-tensor imaging of silent white matter damage. | 
| + | - | nl | Radiology 252(2):518-25 (2009) |
| 81 | 2006 | Molecular mechanisms and therapeutic strategies of chronic renal injury: physiological role of angiotensin II-induced oxidative stress in renal medulla. | 
| + | - | nl | J Pharmacol Sci 100(1):2-8 (2006) |
| 82 | 2006 | Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade. | 
| + | - | nl | J Pharmacol Sci 100(1):9-16 (2006) |
| 83 | 2008 | Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury. | 
| + | - | nl | J Pharmacol Sci 108(4):399-405 (2008) |
| 84 | 2009 | Drug discovery for overcoming chronic kidney disease (CKD): pharmacological effects of mineralocorticoid-receptor blockers. | 
| + | - | nl | J Pharmacol Sci 109(1):1-6 (2009) |
| 85 | 2009 | Drug discovery for overcoming chronic kidney disease (CKD): the endothelin ET B receptor/nitric oxide system functions as a protective factor in CKD. | 
| + | - | nl | J Pharmacol Sci 109(1):7-13 (2009) |
| 86 | 2009 | Drug discovery for overcoming chronic kidney disease (CKD): development of drugs on endothelial cell protection for overcoming CKD. | 
| + | - | nl | J Pharmacol Sci 109(1):14-9 (2009) |
| 87 | 2009 | Drug discovery for overcoming chronic kidney disease (CKD): new therapy for CKD by a (pro)renin-receptor-blocking decoy peptide. | 
| + | - | nl | J Pharmacol Sci 109(1):20-3 (2009) |
| 88 | 2009 | Drug discovery for overcoming chronic kidney disease (CKD): prolyl-hydroxylase inhibitors to activate hypoxia-inducible factor (HIF) as a novel therapeutic approach in CKD. | 
| + | - | nl | J Pharmacol Sci 109(1):24-31 (2009) |
| 89 | 2009 | Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis. | 
| + | - | nl | Europace 11(11):1469-75 (2009) |
| 90 | 2011 | Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysis. | 
| + | - | nl | PLoS One 6(10):e25920 (2011) |
| 91 | 2003 | Nephrology: 4. Strategies for the care of adults with chronic kidney disease. | 
| + | - | nl | CMAJ 168(12):1553-60 (2003) |
| 92 | 2010 | Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. | 
| + | - | nl | Health Technol Assess 14(21):1-184 (2010) |
| 93 | 2007 | Treatment of hypertension in patients with nondiabetic chronic kidney disease. | 
| + | - | nl | Can J Cardiol 23(7):595-601 (2007) |
| 94 | 2009 | Hypertension in dialysis and kidney transplant patients. | 
| + | - | nl | Can J Cardiol 25(5):309-14 (2009) |
| 95 | 2010 | Current status of the measurement of blood hepcidin levels in chronic kidney disease. | 
| + | - | nl | Clin J Am Soc Nephrol 5(9):1681-9 (2010) |
| 96 | 2010 | Survival benefits with vitamin D receptor activation: new insights since 2003. | 
| + | - | nl | Clin J Am Soc Nephrol 5(9):1704-9 (2010) |
| 97 | 2008 | Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results. | 
| + | - | nl | Clin J Am Soc Nephrol 3(6):1718-25 (2008) |
| 98 | 2008 | Improving global outcomes in mineral and bone disorders. | 
| + | - | nl | Clin J Am Soc Nephrol 3 Suppl 3(-):S127-30 (2008) |
| 99 | 2008 | Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? | 
| + | - | nl | Clin J Am Soc Nephrol 3(2):505-21 (2008) |
| 100 | 2002 | Guidelines for initiation of renal replacement therapy: dialysis versus transplantation. | 
| + | - | nl | Saudi J Kidney Dis Transpl 13(3):257-65 (2002) |
| 101 | 2011 | The value of pre-dialysis care. | 
| + | - | nl | Saudi J Kidney Dis Transpl 22(3):419-27 (2011) |